Viander M, Koivikko A
Clin Allergy. 1978 Jul;8(4):387-96. doi: 10.1111/j.1365-2222.1978.tb00474.x.
A 2 year prospective study of thirty-eight birch pollen-sensitive hay fever patients under specific immunotherapy and of nineteen untreated control patients showed a significant correlation between the total seasonal symptom scores of the patients and their clinical sensitivities assessed by the RAST and a graded nasal test. The agreement between a positive nasal test and a positive RAST was 74%. In the early season with low pollen counts the onset of symptoms was significantly associated with high sensitivity of the patients, while many patients showed symptoms in the late season irrespective of their nasal and RAST sensitivity. About 90% of both the treated and the untreated patients reported mild symptoms when the pollen count exceeded 80/m(3) in the early season. 80% of them still had symptoms when the count was below 30/m(3) in the late pollen season. Although hyposensitization therapy had no effect on the occurrence of the mild symptoms, the treated patinets had severe symptoms significantly less often than the untreated ones on days with high pollen counts.
一项针对38名接受特异性免疫疗法的桦树花粉敏感型花粉症患者和19名未接受治疗的对照患者进行的为期2年的前瞻性研究表明,患者的总季节性症状评分与通过放射性变应原吸附试验(RAST)和分级鼻试验评估的临床敏感性之间存在显著相关性。鼻试验阳性与RAST阳性之间的一致性为74%。在花粉计数较低的季节早期,症状的出现与患者的高敏感性显著相关,而许多患者在季节后期出现症状,无论其鼻敏感性和RAST敏感性如何。在季节早期,当花粉计数超过80/m³时,约90%的治疗组和未治疗组患者报告有轻度症状。在花粉季节后期,当计数低于30/m³时,其中80%的患者仍有症状。尽管减敏疗法对轻度症状的发生没有影响,但在花粉计数高的日子里,接受治疗的患者出现严重症状的频率明显低于未治疗的患者。